Fiori et al. studied the immunomodulatory potential of AD-MSCs on CD4+ T cells [20], addressing potential cell-contact dependency in relation to T cell receptor stimulation of whole human peripheral blood mononuclear cells (PBMC). Here, CD4 is linked to Alzheimer disease.